1-11 of 11
Fahad Alsharif, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CEBPA Single Nucleotide Polymorphism (SNP) rs34529039 As An Independent Adverse Prognostic Factor in Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Tarek Owaidah, MD, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mohammed Toulimat, MT, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 1465.
https://doi.org/10.1182/blood.V118.21.1465.1465
Published: 2011
Journal Articles

Rearrangements of 12p in Acute Myeloid Leukemia (AML) Remain a Significant Adverse Prognostic Marker When Patients Are Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Wahiba Chebbo, M.D., Khalid Ibrahim, M.D., Mohammad Bakr, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4464.
https://doi.org/10.1182/blood.V118.21.4464.4464
Published: 2011
Journal Articles

The t(9;11) Confers Good Prognosis in AML Patients Treated with Stem Cell Transplantation As Compared to Non-t(9;11) and Other Adverse-Risk Abnormalities

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Abu Jafar Saleh, M.D., Wahiba Chebbo, M.D., Ghada El Gohary, M.D., Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 2527.
https://doi.org/10.1182/blood.V118.21.2527.2527
Published: 2011
Journal Articles

Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk

Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 1894.
https://doi.org/10.1182/blood.V118.21.1894.1894
Published: 2011
Journal Articles

CD34 Expression in Adult Acute Lymphoblastic Leukemia (ALL) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant in First Remission,

Mahmoud Aljurf, M.D., Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4091.
https://doi.org/10.1182/blood.V118.21.4091.4091
Published: 2011
Journal Articles

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4880.
https://doi.org/10.1182/blood.V118.21.4880.4880
Published: 2011
Journal Articles

FLT3 Internal Tandem Duplication and Kinase Domain Mutations Remain Poor Prognostic Markers in Intermediate Cytogenetic AML After Treatment with Transplant in First Remission

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mohammed Toulimat, MT, Hazzaa Al Zahrani, M.D., Salem Khalil, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4627.
https://doi.org/10.1182/blood.V118.21.4627.4627
Published: 2011
Journal Articles

Validation of Proposed European Leukemia Net Recommendations for Standardized Reporting and Classification of Cytogenetic Risk in AML Patients Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Wahiba Chebbo, M.D., Shad Ahmed, M.D., Fazal Hussain, M.D., Tusneem Elhassan, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4894.
https://doi.org/10.1182/blood.V118.21.4894.4894
Published: 2011
Journal Articles

Dominance of Non-CLL Phenotype of Monoclonal B-Cell Lymphocytosis (MBL) in the Middle East and An Overall MBL Prevalence Comparable to Western Countries

Maher Albitar, M.D., Faisal Rawas, MT, Randa Nounou, M.D., Nasir Bakshi, M.D., Fahed Almhareb, M.D., Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Salem Khalil, M.D., Fahad Alsharif, M.D., Naeem A. Chaudhri, MD, FACP, Hassan El-Solh, MD, Mahmoud Aljurf, M.D.
Journal: Blood
Blood (2011) 118 (21): 4586.
https://doi.org/10.1182/blood.V118.21.4586.4586
Published: 2011
Journal Articles

Trisomy 8 Remains An Intermediate Cytogenetic Risk Factor in Patients with Acute Myeloid Leukemia (AML) Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Mohammad Bakr, M.D., Khalid Ibrahim, M.D., Fazal Hussain, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4900.
https://doi.org/10.1182/blood.V118.21.4900.4900
Published: 2011
Journal Articles

Clinical Relevance of IDH1 and IDH2 Mutations and Single Nucleotide Polymorphism (SNP) rs11554137 in Patients with Acute Myeloid Leukemia Treated with Stem Cell Transplant in First Complete Remission

Hala Abalkhail, PhD, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Hazzaa Al Zahrani, M.D., Randa Nounou, M.D., Ola Altombakty, MT, Fahed Almhareb, MBBS, FACP, Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4643.
https://doi.org/10.1182/blood.V118.21.4643.4643
Published: 2011